Peptan Hydrolyzed Collagen Shows Promise in Bone Health

PARISAt the IOF World Congress on Osteoporosis, Rousselot presented two new in vivo experiments aimed at defining the action of Peptan Hydrolyzed Collagen on bone health. These studies were performed on ovariectomized mice, which are a good model for post-menopausal osteoporosis. The mice received a daily intake of Peptan for 24 weeks. Bone mineral density (BMD), CTX bone resorption marker and biomechanical properties of the bones were measured.

The results confirmed the positive effect of a daily intake of Peptan Hydrolyzed Collagen that had been observed in previous studies. BMD was significantly higher in mice receiving a Peptan-enriched diet than in the control group. Likewise, the bone resorption marker CTX was lower and bone strength was greater when the mice are fed Peptan. The studies also showed Peptans preventive effect on bone loss when given to the mice pre- ovariectomy, as well as its similar effect to raloxifene, a pharmaceutical used for post-menopausal osteoporosis.